CAS: 1448422-61-4
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | 3-(Benzo[d][1,3]dioxol-5-yl)-5-((1-cyclobutylpiperidin-4-yl)methyl)-1,2,4-oxadiazole REF: IN-DA01V775CAS: 1448422-61-4 | 95% | A consultar | Jue 02 Ene 25 |
 | H3R antagonist 1 REF: TM-T200063CAS: 1448422-61-4 | - - - | A consultar | Mar 01 Abr 25 |
 | 3-(1,3-Benzodioxol-5-yl)-5-[(1-cyclobutylpiperidin-4-yl)methyl]-1,2,4-oxadiazole REF: 3D-YHC42261CAS: 1448422-61-4 | Min. 95% | - - - | Producto descatalogado |
![3-(Benzo[d][1,3]dioxol-5-yl)-5-((1-cyclobutylpiperidin-4-yl)methyl)-1,2,4-oxadiazole](https://static.cymitquimica.com/products/IN/thumb/DA01V775.jpg)
3-(Benzo[d][1,3]dioxol-5-yl)-5-((1-cyclobutylpiperidin-4-yl)methyl)-1,2,4-oxadiazole
CAS:1448422-61-4
Fórmula:
C19H23N3O3
Pureza:
95%
Peso molecular:
341.4042
Ref: IN-DA01V775
| 1g | A consultar | ||
| 100mg | 196,00 € | ||
| 250mg | 570,00 € |
Entrega estimada en Estados Unidos, el Jueves 2 de Enero de 2025
H3R antagonist 1
CAS:1448422-61-4
H3R-IN-1 is an effective inverse agonist of the histamine receptor 3 (H3R).
Fórmula:
C19H23N3O3
Forma y color:
Liquid
Peso molecular:
341.4
Ref: TM-T200063
| 10mg | A consultar | ||
| 50mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 1 de Abril de 2025
![3-(1,3-Benzodioxol-5-yl)-5-[(1-cyclobutylpiperidin-4-yl)methyl]-1,2,4-oxadiazole](https://static.cymitquimica.com/products/3D/thumb/YHC42261.jpg)
3-(1,3-Benzodioxol-5-yl)-5-[(1-cyclobutylpiperidin-4-yl)methyl]-1,2,4-oxadiazole
CAS:1448422-61-4
Please enquire for more information about 3-(1,3-Benzodioxol-5-yl)-5-[(1-cyclobutylpiperidin-4-yl)methyl]-1,2,4-oxadiazole including the price, delivery time and more detailed …
Fórmula:
C19H23N3O3
Pureza:
Min. 95%
Peso molecular:
341.4 g/mol
Ref: 3D-YHC42261
| 1g | Descatalogado | Solicitar información | |
| 50mg | Descatalogado | Solicitar información | |
| 100mg | Descatalogado | Solicitar información | |
| 250mg | Descatalogado | Solicitar información | |
| 500mg | Descatalogado | Solicitar información |
